Please try another search
Daewoong Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical products in South Korea and internationally. It offers products in therapeutic areas, such as central nervous system, endocrinology, musculoskeletal, nephrology, antineoplastic, cardiovascular, gastrointestinal, metabolic, antiviral, analgesic, antacid, and digestive diseases, as well as wound, iron supplements, and muti-vitamins. The company also provides COVID-19 PCR kit, COVID-19 IgG/IgM RDT, and viral transport medium medical devices. The company was founded in 1945 and is headquartered in Seoul, South Korea.
Name | Age | Since | Title |
---|---|---|---|
Chang-Jae Lee | 45 | 2021 | CEO & Executive Director |
Dae-duk Kim | - | 2022 | Independent Outside Director |
Yong-Jin Kim | - | 2023 | Independent Outside Director |
Seongsoo Park | - | 2023 | CEO & Executive Director |
Eunkyeong Park | - | 2024 | Executive Director |
Youngmin Cho | - | 2024 | Independent Outside Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review